These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation. Abed Y, Pizzorno A, Boivin G. Antimicrob Agents Chemother; 2012 Aug; 56(8):4375-80. PubMed ID: 22664977 [Abstract] [Full Text] [Related]
11. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice. Smee DF, Hurst BL, Wong MH, Tarbet EB, Babu YS, Klumpp K, Morrey JD. Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577 [Abstract] [Full Text] [Related]
12. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice. Tarbet EB, Maekawa M, Furuta Y, Babu YS, Morrey JD, Smee DF. Antiviral Res; 2012 Apr; 94(1):103-10. PubMed ID: 22429564 [Abstract] [Full Text] [Related]
13. Peramivir (Rapivab): an IV neuraminidase inhibitor for treatment of influenza. Med Lett Drugs Ther; 2015 Feb 02; 57(1461):17-9. PubMed ID: 25629811 [No Abstract] [Full Text] [Related]
16. Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model. Farooqui A, Huang L, Wu S, Cai Y, Su M, Lin P, Chen W, Fang X, Zhang L, Liu Y, Zeng T, Paquette SG, Khan A, Kelvin AA, Kelvin DJ. Antimicrob Agents Chemother; 2015 Dec 02; 59(12):7255-64. PubMed ID: 26369969 [Abstract] [Full Text] [Related]
17. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG. Antimicrob Agents Chemother; 2001 Oct 02; 45(10):2723-32. PubMed ID: 11557461 [Abstract] [Full Text] [Related]
18. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection. Sugaya N, Kohno S, Ishibashi T, Wajima T, Takahashi T. Antimicrob Agents Chemother; 2012 Jan 02; 56(1):369-77. PubMed ID: 22024821 [Abstract] [Full Text] [Related]
19. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates. Itoh Y, Shichinohe S, Nakayama M, Igarashi M, Ishii A, Ishigaki H, Ishida H, Kitagawa N, Sasamura T, Shiohara M, Doi M, Tsuchiya H, Nakamura S, Okamatsu M, Sakoda Y, Kida H, Ogasawara K. Antimicrob Agents Chemother; 2015 Aug 02; 59(8):4962-73. PubMed ID: 26055368 [Abstract] [Full Text] [Related]
20. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme. Bantia S, Upshaw R, Babu YS. Antiviral Res; 2011 Sep 02; 91(3):288-91. PubMed ID: 21722670 [Abstract] [Full Text] [Related] Page: [Next] [New Search]